Cargando…

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance

Highly active antiretroviral (ARV) therapy has been used for many years, but the use in low- and middle-income countries of antiretroviral drugs with low genetic barrier to resistance, combined with limited availability of viral load testing, has led to higher rates of acquired drug resistance, sust...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charpentier, Charlotte, Le Hingrat, Quentin, Ferré, Valentine Marie, Damond, Florence, Descamps, Diane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967014/ https://www.ncbi.nlm.nih.gov/pubmed/36851754 http://dx.doi.org/10.3390/v15020540

Ejemplares similares

HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolution
por: Visseaux, Benoit, et al.
Publicado: (2021)

Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements
por: Visseaux, Benoit, et al.
Publicado: (2021)

Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
por: Charpentier, Charlotte, et al.
Publicado: (2020)

HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man
por: Cazals, Nicolas, et al.
Publicado: (2018)

Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa
por: Tchounga, Boris K., et al.
Publicado: (2023)

Transfusion-Acquired HIV: History, Evolution of Screening Tests, and Current Challenges of Unreported Antiretroviral Drug Use in Brazil
por: Nishiya, Anna S., et al.
Publicado: (2022)

G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to Raltegravir whereas Y143C does not
por: Ni, Xiao-Ju, et al.
Publicado: (2011)

Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d’Ivoire West Africa
por: Tchounga, Boris K., et al.
Publicado: (2020)

Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants
por: Perrier, Marine, et al.
Publicado: (2018)

An appeal for large scale production of antiretroviral drugs in Africa
por: Martial, Nkamedjie Pete Patrick, et al.
Publicado: (2016)

Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection
por: Delaroche, Lucie, et al.
Publicado: (2021)

No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis
por: Le Hingrat, Quentin, et al.
Publicado: (2020)

Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations
por: Charpentier, Charlotte, et al.
Publicado: (2018)

Predictive Value of Liver Enzymes and Inflammatory Biomarkers for the Severity of Liver Fibrosis Stage in HIV/HCV Co-Infected Patients
por: Charpentier, Charlotte, et al.
Publicado: (2013)

Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates
por: Visseaux, Benoit, et al.
Publicado: (2015)

Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and Therapy
por: Trauner, Andrej, et al.
Publicado: (2014)

External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations
por: Ji, Hezhao, et al.
Publicado: (2020)

Evolution of Drug Interactions With Antiretroviral Medication in People With HIV
por: El Moussaoui, Majdouline, et al.
Publicado: (2020)

Hidden costs of antiretroviral treatment: the public health efficiency of drug packaging
por: Andreu-Crespo, Àngels, et al.
Publicado: (2015)

Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection
por: Visseaux, Benoit, et al.
Publicado: (2020)

The Evolution and Future Development of Attention Networks
por: Posner, Michael I
Publicado: (2023)

Drug-resistant tuberculosis control in China: progress and challenges
por: Long, Qian, et al.
Publicado: (2016)

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)
por: Matheron, Sophie, et al.
Publicado: (2018)

Artificial Intelligence and the Future of the Drug Safety Professional
por: Danysz, Karolina, et al.
Publicado: (2018)

microRNAs: a role in drug resistance in parasitic nematodes?
por: Devaney, Eileen, et al.
Publicado: (2010)

Photobactericides—A Local Option against Multi-Drug Resistant Bacteria
por: Wainwright, Mark, et al.
Publicado: (2013)

Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis
por: Gupta, Aastha, et al.
Publicado: (2022)

Mitochondria in colorectal cancer stem cells - a target in drug resistance
por: Rainho, Mateus de Almeida, et al.
Publicado: (2023)

High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021
por: Sadio, Arnold Junior, et al.
Publicado: (2023)

HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users
por: Budambula, Valentine, et al.
Publicado: (2015)

Current Perspectives on HIV-1 Antiretroviral Drug Resistance
por: Iyidogan, Pinar, et al.
Publicado: (2014)

Is antimicrobial resistance evolution accelerating?
por: Witzany, Christopher, et al.
Publicado: (2020)

Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study
por: Bouzid, Donia, et al.
Publicado: (2023)

Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2015)

Injectable Antiretroviral Drugs: Back to the Future
por: Berruti, Marco, et al.
Publicado: (2021)

Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2
por: Wirden, Marc, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eg70htdc7cgp66ksvbvg7iqn5v